These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 35860577)

  • 1. Identification and Validation of Immune-Related Long Non-Coding RNA Signature for Predicting Immunotherapeutic Response and Prognosis in NSCLC Patients Treated With Immunotherapy.
    Ma J; Zhang M; Yu J
    Front Oncol; 2022; 12():899925. PubMed ID: 35860577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Investigation of Immune-Related lncRNA Landscape Reveals a Potential Long Non-Coding RNA Signature for Predicting Prognosis in Renal Cell Carcinoma.
    Liu K; Li Z; Ruan D; Wang H; Wang W; Zhang G
    Front Genet; 2022; 13():890641. PubMed ID: 35860468
    [No Abstract]   [Full Text] [Related]  

  • 3. Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma.
    Xu Y; Chen Y; Niu Z; Yang Z; Xing J; Yin X; Guo L; Zhang Q; Yang Y; Han Y
    Front Surg; 2022; 9():860806. PubMed ID: 35937602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the ferroptosis-related long non-coding RNAs signature to improve the prognosis prediction and immunotherapy response in patients with NSCLC.
    Li M; Zhang Y; Fan M; Ren H; Chen M; Shi P
    BMC Med Genomics; 2021 Dec; 14(1):286. PubMed ID: 34861872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.
    Zhou M; Guo M; He D; Wang X; Cui Y; Yang H; Hao D; Sun J
    J Transl Med; 2015 Jul; 13():231. PubMed ID: 26183581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of endocrine resistance-related and immune-related long non-coding RNA (lncRNA) signatures for predicting endocrinotherapy response and prognosis in breast cancer.
    Yang M; Sun Y; Ji H; Zhang Q
    Ann Transl Med; 2022 Dec; 10(24):1399. PubMed ID: 36660659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel GIRlncRNA Signature for Predicting the Clinical Outcome and Therapeutic Response in NSCLC.
    Zhang Q; Liu X; Chen Z; Zhang S
    Front Pharmacol; 2022; 13():937531. PubMed ID: 35991889
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of a 4-lncRNA signature predicting prognosis of patients with non-small cell lung cancer: a multicenter study in China.
    Wang RQ; Long XR; Ge CL; Zhang MY; Huang L; Zhou NN; Hu Y; Li RL; Li Z; Chen DN; Zhang LJ; Wen ZS; Mai SJ; Wang HY
    J Transl Med; 2020 Aug; 18(1):320. PubMed ID: 32819367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A innovative prognostic symbol based on neutrophil extracellular traps (NETs)-related lncRNA signature in non-small-cell lung cancer.
    Fang C; Liu F; Wang Y; Yuan S; Chen R; Qiu X; Qian X; Zhang X; Xiao Z; Wang Q; Fu B; Li Y
    Aging (Albany NY); 2021 Jul; 13(13):17864-17879. PubMed ID: 34257164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of tumor immune infiltration-associated lncRNAs for improving prognosis and immunotherapy response of patients with non-small cell lung cancer.
    Sun J; Zhang Z; Bao S; Yan C; Hou P; Wu N; Su J; Xu L; Zhou M
    J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32041817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune checkpoints related-LncRNAs can identify different subtypes of lung cancer and predict immunotherapy and prognosis.
    Zhang H; Liu M; Du G; Yu B; Ma X; Gui Y; Cao L; Li X; Tan B
    J Cancer Res Clin Oncol; 2022 Jul; 148(7):1597-1612. PubMed ID: 35296921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma.
    Peng Y; Wu G; Qiu X; Luo Y; Zou Y; Wei X; Li A
    Front Genet; 2022; 13():916024. PubMed ID: 36110223
    [No Abstract]   [Full Text] [Related]  

  • 13. Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature.
    Ma W; Zhao F; Yu X; Guan S; Suo H; Tao Z; Qiu Y; Wu Y; Cao Y; Jin F
    J Transl Med; 2020 Nov; 18(1):442. PubMed ID: 33225954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a B cell-related gene pairs signature for predicting prognosis and immunotherapeutic response in non-small cell lung cancer.
    Li X; Wang R; Wang S; Wang L; Yu J
    Front Immunol; 2022; 13():989968. PubMed ID: 36389757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying a Hypoxia-Related Long Non-Coding RNAs Signature to Improve the Prediction of Prognosis and Immunotherapy Response in Hepatocellular Carcinoma.
    Tang P; Qu W; Wang T; Liu M; Wu D; Tan L; Zhou H
    Front Genet; 2021; 12():785185. PubMed ID: 34917132
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of N6-Methyladenosine-Associated Long Non-coding RNAs for Immunotherapeutic Response and Prognosis in Patients With Pancreatic Cancer.
    Yu X; Dong P; Yan Y; Liu F; Wang H; Lv Y; Song M; Yao Q; Hu S
    Front Cell Dev Biol; 2021; 9():748442. PubMed ID: 34621754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma.
    Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M
    Front Oncol; 2021; 11():663263. PubMed ID: 34123820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of immune-related lncRNA prognostic signatures for melanoma.
    Xiao B; Liu L; Li A; Wang P; Xiang C; Li H; Xiao T
    Immun Inflamm Dis; 2021 Sep; 9(3):1044-1054. PubMed ID: 34077998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Immune-Related Long Non-Coding RNA Signature to Predict the Prognosis of Ewing's Sarcoma Based on a Machine Learning Iterative Lasso Regression.
    Ren EH; Deng YJ; Yuan WH; Zhang GZ; Wu ZL; Li CY; Xie QQ
    Front Cell Dev Biol; 2021; 9():651593. PubMed ID: 34124041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An exosome-derived lncRNA signature identified by machine learning associated with prognosis and biomarkers for immunotherapy in ovarian cancer.
    Cui Y; Zhang W; Lu W; Feng Y; Wu X; Zhuo Z; Zhang D; Zhang Y
    Front Immunol; 2024; 15():1228235. PubMed ID: 38404588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.